Duchenne muscular dystrophy (DMD) is an inherited, severe muscle wasting di
sease caused by the loss of the cytoskeletal protein, dystrophin. Patients
usually die in their late teens or early twenties of cardiac or respiratory
failure. We have previously demonstrated that the dystrophin related prote
in, utrophin is able to compensate for the loss of dystrophin in the mdx mo
use, the mouse model of the disease. Expression of a utrophin transgene und
er the control of an HSA promoter results in localization of utrophin to th
e sarcolemma and prevents the muscle pathology. Here we show that the over-
expression of full-length utrophin in a broad range of tissues is not detri
mental in the mdx mouse. These findings have important implications for the
feasibility of the up-regulation of utrophin in therapy for DMD since they
suggest that tissue specific up-regulation may not be necessary. (C) 2001
Elsevier Science B.V. All rights reserved.